Existing data sources for clinical epidemiology: Aarhus University Prescription Database

Clinical Epidemiology

Volumn 2, Issue 1, 2010, Pages 273-279

  Ehrenstein, Vera ^a   Antonsen, Sussie ^a   Pedersen, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epidemiology; Prescriptions; Registry based research

Indexed keywords

NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL;

AARHUS UNIVERSITY PRESCRIPTION DATABASE; ACCESS TO INFORMATION; ARTICLE; CHRONIC PAIN; DATA BASE; DENMARK; DRUG CLASSIFICATION; DRUG INFORMATION; DRUG UTILIZATION; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; MEDICAL RECORD; PHARMACY; PRESCRIPTION; REIMBURSEMENT;

EID: 78650715750     PISSN: None     EISSN: 11791349     Source Type: Book Series    
DOI: 10.2147/CLEP.S13458     Document Type: Article

References (33)

1. Furu K, Wettermark B, Andersen M, Martikainen JE, Almarsdottir AB, Sørensen HT. The Nordic countries as a cohort for pharmacoepidemiological research. Basic Clin Pharmacol Toxicol. 2010;106(2):86-94.
2. Hallas J. Conducting pharmacoepidemiologic research in Denmark. Pharmacoepidemiol Drug Saf. 2001;10(7):619-623.
3. Frank L. Epidemiology. The epidemiologist's dream: Denmark. Science. 2003;301(5630):163.
4. Nielsen GL, Sørensen HT, Pedersen AB, Sabroe S. Analyses of data quality in registries concerning diabetes mellitus - a comparison between a population based hospital discharge and an insulin prescription registry. J Med Syst. 1996;20(1):1-10.
5. Danish Regions. The Danish regions in brief. 2008. Accessed 2010 Oct 6. Available from: http://www.regioner.dk/In%20English/Publications%20and%20Policy%20Papers/The%20Regions%20in%20Denmark.aspx
6. Nielsen GL, Sørensen HT, Zhou W. The Pharmacoepidemiologic Prescription Database of North Jutland - a valid tool in pharmacoepidemiological research. Int J Risk Safety Med. 1997;10:203-205.
7. Ministry of Interior and Health. Health Care in Denmark 2008. Accessed 2010 May 17. Available from: http://www.sum.dk/Aktuelt/Publikationer/Publikationer/UK_Healthcare_in_DK.aspx
8. Danish Medicines Agency. Medicinal Products Statistics. Denmark, 2004-2008. Total sales. Accessed 2010 Oct 6. Available from: http://www.dkma.dk/db/filarkiv/7004/Samlet%20salg%20af%20llgemidler%202004-2008.pdf
9. Danish Medicines Agency. Reimbursement. Accessed 2010 Oct 6. Available from: http://www.dkma.dk/1024/visUKLSArtikel.asp?artikelIDa1469
10. Danish Medicines Agency. Medicines eligible for reimbursement [in Danish: Skrivelse om tilskudsberettigede lægemidler]. Accessed 2010 Oct 6. Available from: http://www.laegemiddelstyrelsen.dk/db/filarkiv/5195/tilskudsberettigede.pdf
11. Danish Medicines Agency. Reassessment of reimbursement status for medicinal products. Accessed 2010 Oct 6. Available from: http://www.dkma.dk/1024/visUKLSArtikel.asp?artikelIDd6301
12. Pedersen CB, Gotzsche H, Moller JO, Mortensen PB. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53(4):441-449.
13. WHO Collaborating Centre for Drug Statistics Methodology Norwegian Institute of Public Health. WHO ATC/DDD Index. Accessed 2010 Oct 6. Available from: http://www.whocc.no/atc_ddd_index/
14. Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry (unpublished work).
15. Frank L. Epidemiology. When an entire country is a cohort. Science. 2000;287(5462):2398-2399.
16. Knudsen LB, Olsen J. The Danish Medical Birth Registry. Dan Med Bull. 1998;45(3):320-323.
17. Persondataloven (Data Protection Act). Accessed 2010 Oct 6. Available from: http://www.datatilsynet.dk/lovgivning/persondataloven/Englishversion. Accessed 2010 Oct 6. Available from: http://www.datatilsynet.dk/english/the-act-on-processing-of-personal-data/
18. Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case-control study. BMJ. 2001;322(7281):266-270.
19. Pedersen L, Norgaard M, Rothman KJ, Sorensen HT. Loratadine during pregnancy and hypospadias. Epidemiology. 2008;19(2):359-360.
20. Norgaard M, Pedersen L, Gislum M, et al. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study. J Antimicrob Chemother. 2008;62(1):172-176.
21. Wogelius P, Norgaard M, Gislum M, et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology. 2006;17(6):701-704.
22. Sorensen HT, Pedersen L, Skriver MV, Norgaard M, Norgard B, Hatch EE. Use of clomifene during early pregnancy and risk of hypospadias: population based case-control study. BMJ. 2005;330(7483):126-127.
23. Norgaard M, Skriver MV, Sorensen HT, Schonheyder HC, Pedersen L. Risk of miscarriage for pregnant users of pivmecillinam: a populationbased case-control study. APMIS. 2008;116(4):278-283.
24. Johnsen SP, Larsson H, Tarone RE, et al. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med. 2005;165(9):978-984.
25. Fryzek JP, Poulsen AH, Lipworth L, et al. A cohort study of antihypertensive medication use and breast cancer among Danish women. Breast Cancer Res Treat. 2006;97(3):231-236.
26. Norgaard M, Jacobsen J, Gasse C, Pedersen L, Mortensen PB, Sorensen HT. Selective serotonin reuptake inhibitors and risk of acute pancreatitis: a population-based case-control study. J Clin Psychopharmacol. 2007;27(3):259-262.
27. Lash TL, Pedersen L, Cronin-Fenton D, et al. Tamoxifen's protection against breast cancer recurrence is not reduced by concurrent use of the SSRI citalopram. Br J Cancer. 2008;99(4):616-621.
28. Cronin-Fenton D, Lash TL, Sorensen HT. Selective serotonin reuptake inhibitors and adjuvant tamoxifen therapy: risk of breast cancer recurrence and mortality. Future Oncol. 2010;6(6):877-880.
29. Lash TL, Cronin-Fenton D, Ahern TP, et al. Breast cancer recurrence risk related to concurrent use of SSRI antidepressants and tamoxifen. Acta Oncol. 2010;49(3):305-312.
30. Thrane N, Olesen C, Schonheyder HC, Sorensen HT. Socioeconomic factors and prescription of antibiotics in 0- to 2-year-old Danish children. J Antimicrob Chemother. 2003;51(3):683-689.
31. Thomsen RW, Johnsen SP, Olesen AV, et al. Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study. Br J Clin Pharmacol. 2005;60(5):534-542.
32. Olesen C, Thrane N, Henriksen TB, Ehrenstein V, Olsen J. Associations between socio-economic factors and the use of prescription medication during pregnancy: a population-based study among 19,874 Danish women. Eur J Clin Pharmacol. 2006;62(7):547-553.
33. Mortensen JT, Olesen AV, Boggild H, Olsen J, Westergard-Nielsen NC. Socioeconomic correlates of drug use based on prescription data: a population-based cross-sectional register study in Denmark 1999. Dan Med Bull. 2007;54(1):62-66.